文献速递外周血管心血管PETCTMR

大血管炎中人工动脉移植物的FDG摄取对活动性疾病不具特异性

FDG Uptake by Prosthetic Arterial Grafts in Large Vessel Vasculitis Is Not Specific for Active Disease.
PubMed 文献 · JACC Cardiovasc Imaging · 2017-01-18

这项前瞻性观察研究纳入26例在大血管炎(LVV)中接受移植手术超过6个月的大动脉炎(TA)患者,评估移植物周围[18F]FDG摄取与疾病活动性的关系。结果显示26例中23例存在显著移植物周围摄取,且与疾病活动性无关;连续MRA在25/26例中未显示动脉进展。作者据此在血培养阴性、临床静止且CRP正常或稳定升高时选择不升级免疫抑制治疗,而以MRA监测进展。

要点

  • 大血管炎患者移植术后超过6个月,移植物周围[18F]FDG摄取常见,26例中23例有显著摄取。
  • 移植物特异性[18F]FDG摄取与疾病活动性无关,不反映临床相关活动或进展。
  • 连续MRA在25/26例中未显示动脉进展,仅1例 native 动脉轻微进展。

核心结论

  • 局限于动脉移植部位的显著[18F]FDG摄取不反映临床相关疾病活动或进展。

研究设计与样本

  • 前瞻性观察研究,从2家三级转诊中心大型队列中纳入26例接受移植手术超过6个月的大动脉炎患者,行[18F]FDG-PET/CT并以肝摄取为参照对移植物和 native 动脉摄取评分0–3分,计算移植物周围SUVmax,并以连续MRA评估动脉进展。

关键影像表现/征象

  • 26例中23例(23/26)存在显著移植物周围[18F]FDG摄取。
  • 移植物周围[18F]FDG摄取评分中位数3分(IQR 3–3),高于 native 主动脉的1分(IQR 0–1),p < 0.001。
  • 移植物周围平均SUVmax为4.21 ± 1.46。
  • 9例接受重复PET/CT扫描,尽管治疗增加,移植物特异性摄取未见变化。
  • 连续MRA在25/26例中未显示动脉进展,剩余1例仅见 native 动脉轻微进展。

诊断标准与关键数值

  • [18F]FDG摄取以肝摄取为参照按0–3分评分,移植物周围[18F]FDG摄取评分中位数3分(IQR 3–3)高于 native 主动脉1分(IQR 0–1),p < 0.001。
  • 移植物周围平均SUVmax为4.21 ± 1.46。

临床应用与阅片要点

  • 所有患者均无发热且血培养阴性。
  • 在血培养阴性、临床静止的大动脉炎、C反应蛋白正常或稳定升高时,作者选择不升级治疗并以MRA监测进展。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: This study investigated the incidence and clinical significance of arterial graft-associated uptake of fluorodeoxyglucose in large-vessel vasculitis (LVV).

BACKGROUND: The role of 18F-labeled fluorodeoxyglucose-positron emission tomography/computed tomography ([18F]FDG-PET/CT) in the management of LVV remains to be defined. Although [18F]FDG uptake at arterial graft sites raises concerns regarding active arteritis or infection, its clinical significance in LVV has never been formally studied.

METHODS: An observational prospective study sought to identify patients with Takayasu arteritis (TA) undergoing [18F]FDG-PET/CT more than 6 months after graft surgery from a large cohort of patients from 2 tertiary referral centers. [18F]FDG uptake by the graft and native arteries was scored on a scale of 0 to 3 relative to hepatic uptake, and periprosthetic maximum standardized uptake value (SUVmax) was calculated. Periprosthetic [18F]FDG uptake in active disease was compared with that in inactive disease, and arterial progression was assessed by prospective magnetic resonance angiography (MRA).

RESULTS: Twenty-six subjects with TA were enrolled. All were afebrile with negative blood culture. Periprosthetic uptake was significant in 23 of 26 patients, and the mean SUVmax was 4.21 ± 1.46. Median periprosthetic [18F]FDG uptake score (3; interquartile range [IQR]: 3 to 3) was higher than in native aorta (1; IQR: 0 to 1; p < 0.001). Graft-specific [18F]FDG uptake was unrelated to disease activity. Despite the high frequency of graft-associated [18F]FDG uptake, sequential MRAs did not reveal arterial progression in 25 of 26 patients; the 1 remaining case showed minor progression limited to native arteries. Nine patients underwent repeated PET/CT scanning without showing changes in graft-specific uptake, despite increased treatment.

CONCLUSIONS: Significant [18F]FDG uptake that is confined to arterial graft sites in patients with LVV does not reflect clinically relevant disease activity or progression. To minimize exposure to immunosuppression and in the face of negative blood culture, clinically quiescent arteritis, normal or stably raised C-reactive protein levels, we elected not to escalate treatment and monitor progression with MRA.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Youngstein T, Tombetti E, Mukherjee J, et al. FDG Uptake by Prosthetic Arterial Grafts in Large Vessel Vasculitis Is Not Specific for Active Disease. JACC Cardiovasc Imaging. 2017. PMID: 28109928. doi:10.1016/j.jcmg.2016.09.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。